Based on adoptive transfer of tumor-reactive CD4 T cells or CD4 T cell depletion, it was initially demonstrated that CD4 T cells are necessary for protection against tumors lacking MHC-II [23,24,25,26,27,28,29]. The gene discussed is CD4; the disease is neoplasm.